4D Molecular Therapeutics (FDMT) Earnings Date & Reports
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FDMT is expected to report earnings to fall 15.48% to -72 cents per share on August 07
Q2'25
Est.
$-0.73
Q1'25
Est.
$-0.86
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.11
Q2'24
Beat
by $0.05
The last earnings report on May 08 showed earnings per share of -86 cents, meeting the estimate of -86 cents. With 179.71K shares outstanding, the current market capitalization sits at 181.13M.